Foghorn Therapeutics Inc.
NASDAQ:FHTX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Foghorn Therapeutics Inc.
NASDAQ:FHTX
|
US |
|
A
|
Allstate Corp
XHAM:ALS
|
US |
|
Credit Agricole SA
PAR:ACA
|
FR |
|
Sirona Biochem Corp
XTSX:SBM
|
CA |
|
SKF AB
F:SKFB
|
SE |
|
V
|
Verbund AG
XHAM:OEWA
|
AT |
|
D
|
Deutsche Boerse AG
XHAM:DB1
|
DE |
|
C
|
Cushman & Wakefield PLC
F:2IY
|
UK |
|
Basic Fit NV
F:B4F
|
NL |
|
A
|
Ameresco Inc
SWB:4AM
|
US |
|
P
|
Pine Cliff Energy Ltd
OTC:PIFYF
|
CA |
|
N
|
New York Times Co
XMUN:NYT
|
US |
|
A
|
Addus Homecare Corp
F:A41
|
US |
|
E
|
Easterly Government Properties Inc
F:E05
|
US |
|
M
|
MC Group PCL
SET:MC
|
TH |
|
C
|
Capital One Financial Corp
XBER:CFX
|
US |
Wall St Price Targets
FHTX Price Targets Summary
Foghorn Therapeutics Inc.
According to Wall Street analysts, the average 1-year price target for
FHTX is 11.67 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FHTX's stock price target?
Price Target
11.67
USD
According to Wall Street analysts, the average 1-year price target for
FHTX is 11.67 USD with a low forecast of 9.09 USD and a high forecast of 14.7 USD.
What is the Revenue forecast for Foghorn Therapeutics Inc.?
Projected CAGR
5%
The compound annual growth rate for Revenue over the next 3 years is 5%.